We are live on
!
Find out more
EOJOAM
E. Ohman J:or Asset Management Portfolio holdings
AUM
$4.3B
1-Year Est. Return
29.55%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.59B
AUM Growth
+$64.1M
(+4.2%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
2.76%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
386
New
11
Increased
148
Reduced
18
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$16.9M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$12.8M |
| 3 |
Voya Financial
VOYA
|
+$7.06M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$4.55M |
| 5 |
Citigroup
C
|
+$4.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$12.3M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
+$10.2M |
| 3 |
Starbucks
SBUX
|
+$9.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$9.03M |
| 5 |
NVIDIA
NVDA
|
+$4.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Financials | 18.49% |
| 3 | Communication Services | 15.82% |
| 4 | Consumer Discretionary | 12.71% |
| 5 | Healthcare | 12.71% |
Similar funds
IWM
CW
IUHSA
MYIA
NEI
CIC
SLI
E. Ohman J:or Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, E. Ohman J:or Asset Management held 386 positions worth $1.59B, up 4.2% from $1.52B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
E. Ohman J:or Asset Management's Q3 2019 filing shows 11 new, 148 increased, 18 reduced and 14 closed positions. Its largest new stake was Centene: 347,989 shares worth $15.1M. The largest sale was Regeneron Pharmaceuticals, an estimated $12.3M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Communication Services.
- E. Ohman J:or Asset Management's largest Q3 2019 buy was Centene: 347,989 shares worth $15.1M.
- E. Ohman J:or Asset Management added most to BioMarin Pharmaceuticals in Q3 2019, an estimated $12.8M increase.
- E. Ohman J:or Asset Management's biggest Q3 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $12.3M.
- E. Ohman J:or Asset Management fully exited Sage Therapeutics in Q3 2019, selling an estimated $10.2M.
- E. Ohman J:or Asset Management's ten largest holdings make up 39% of its $1.59B portfolio in Q3 2019.
- E. Ohman J:or Asset Management opened 11 new positions and closed 14 in Q3 2019.
- E. Ohman J:or Asset Management's portfolio value rose 4.2% quarter-over-quarter to $1.59B.
Based on E. Ohman J:or Asset Management's 13F filing for Q3 2019, filed 5 Apr 2024.